Research location
Tbilisi
Georgia
Advertisement
Research activity in Tbilisi
GeorgiaCureCurrent currently publishes aggregate city-level research activity for this location: 292 trials and 1,075 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Tbilisi
292 linked trials · page 2 of 6Cranberry Proanthocyanidins and Lactobacilli for Recurrent UTI Prevention in Type 2 DiabetesNCT07832409 · 2025-09-10 · 1 site observation
COMPLETED
A Study of SPY072 in Rheumatic DiseaseNCT07148414 · 2025-08-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)NCT06940154 · 2025-08-12 · 6 site observations
COMPLETED
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)NCT06940141 · 2025-08-08 · 6 site observations
COMPLETED
CRF2 Agonist for the Treatment of Worsening Heart FailureNCT06815471 · 2025-08-07 · 9 site observations
SUSPENDED
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)NCT07211633 · 2025-07-09 · 8 site observations
ACTIVE_NOT_RECRUITING
Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple SclerosisNCT06847724 · 2025-06-10 · 8 site observations
ACTIVE_NOT_RECRUITING
Study of GS-0151 in Participants With Rheumatoid ArthritisNCT06902519 · 2025-05-14 · 1 site observation
ACTIVE_NOT_RECRUITING
The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After SternotomyNCT07376070 · 2025-04-14 · 2 site observations
ACTIVE_NOT_RECRUITING
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)NCT06726265 · 2025-03-21 · 3 site observations
ACTIVE_NOT_RECRUITING
A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung CancerNCT06939595 · 2025-01-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)NCT06700343 · 2025-01-13 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisNCT06754462 · 2025-01-10 · 3 site observations
ACTIVE_NOT_RECRUITING
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)NCT06687369 · 2024-12-30 · 9 site observations
ACTIVE_NOT_RECRUITING
A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringNCT06788509 · 2024-12-30 · 1 site observation
ENROLLING_BY_INVITATION
Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)NCT06643117 · 2024-10-03 · 1 site observation
TERMINATED
A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [Proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid ArthritisNCT06596772 · 2024-10-03 · 7 site observations
COMPLETED
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)NCT06430866 · 2024-09-12 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerNCT06311721 · 2024-09-09 · 5 site observations
ACTIVE_NOT_RECRUITING
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974 · 2024-09-04 · 3 site observations
ACTIVE_NOT_RECRUITING
Volrustomig Priming Regimens Exploratory Phase II Platform StudyNCT06448754 · 2024-08-27 · 5 site observations
ACTIVE_NOT_RECRUITING
Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic ResistanceNCT06174623 · 2024-08-01 · 4 site observations
UNKNOWN
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With SurgeryNCT06161441 · 2024-07-16 · 8 site observations
ACTIVE_NOT_RECRUITING
Phase III Long-Term Extension Study With DexpramipexoleNCT06388889 · 2024-06-12 · 6 site observations
TERMINATED
A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)NCT06159790 · 2024-04-29 · 1 site observation
COMPLETED
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.NCT06372145 · 2024-04-16 · 3 site observations
ACTIVE_NOT_RECRUITING
REGN5381 in Adult Participants With Heart Failure With Reduced Ejection FractionNCT06237309 · 2024-04-11 · 1 site observation
TERMINATED
A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung CancerNCT06348199 · 2024-03-12 · 6 site observations
ACTIVE_NOT_RECRUITING
Ryme Medical TLD Pilot StudyNCT05967091 · 2024-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)NCT06215911 · 2024-02-13 · 7 site observations
COMPLETED
Airway Bypass - Safety and Feasibility StudyNCT06249529 · 2024-01-26 · 1 site observation
UNKNOWN
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPDNCT06208306 · 2024-01-11 · 3 site observations
COMPLETED
Pacertool Early Feasibility Study - Safety and PerformanceNCT06103539 · 2023-12-01 · 1 site observation
UNKNOWN
Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).NCT06264674 · 2023-11-27 · 3 site observations
COMPLETED
Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance TherapyNCT06029595 · 2023-11-26 · 7 site observations
TERMINATED
Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation GlaucomasNCT06154330 · 2023-11-20 · 1 site observation
UNKNOWN
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung CancerNCT06091943 · 2023-11-16 · 1 site observation
COMPLETED
A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid ArthritisNCT06073093 · 2023-11-07 · 1 site observation
COMPLETED
A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveNCT05879822 · 2023-10-30 · 10 site observations
ACTIVE_NOT_RECRUITING
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)NCT05952557 · 2023-10-05 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerNCT05848011 · 2023-09-28 · 7 site observations
COMPLETED
Study of GS-0272 in Participants With Rheumatoid ArthritisNCT06031415 · 2023-09-28 · 1 site observation
TERMINATED
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)NCT06041269 · 2023-08-31 · 6 site observations
ACTIVE_NOT_RECRUITING
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung CancerNCT05800015 · 2023-08-08 · 9 site observations
ACTIVE_NOT_RECRUITING
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT05785767 · 2023-06-30 · 7 site observations
ACTIVE_NOT_RECRUITING
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel ChemotherapyNCT05747794 · 2023-05-22 · 1 site observation
TERMINATED
ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer StudyNCT05596409 · 2023-05-19 · 3 site observations
ACTIVE_NOT_RECRUITING
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary HypertensionNCT05951166 · 2023-05-05 · 2 site observations
ACTIVE_NOT_RECRUITING
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)NCT05557591 · 2023-04-21 · 5 site observations
ACTIVE_NOT_RECRUITING
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)NCT05816252 · 2023-04-19 · 3 site observations
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.